… recruit and direct the cells own editing machinery called ADAR (adenosine deaminase acting on RNA). EONs will guide the ADARs to perform a single nucleotide change at the RNA level …
… disease, by using editing oligonucleotides to attract ADAR (Adenosine Deaminase Acting on RNA) at a specific … an edit. At ProQR, our deep commitment to these types of advancements is what sets us apart. The offices at our …
… Strategic collaborations like this can help to drive the advancement of an early-stage technology, like Axiomer, … expansion of our collaboration with Lilly. Lilly is a leader in innovative RNA science, making them a great partner … partnership is another validation of our leadership in ADAR-mediated RNA editing, our robust IP estate, and the …
Bart Klein was at the forefront of ProQR's Axiomer® RNA editing technology development. This platform technology makes it possible to use the cells own machinery to reverse mutations that cause a genetic disease. Read the interview.
